Controversies in the management of Kawasaki disease

Kawasaki, 1974, A new infantile acute febrile mucocutaneous lymph node syndrome (MLNS) prevailing in Japan, Pediatrics, 54, 271, 10.1542/peds.54.3.271 Newburger, 1991, A single intravenous infusion of gamma globulin as compared with four infusions in the treatment of acute Kawasaki syndrome, New England Journal of Medicine, 324, 1633, 10.1056/NEJM199106063242305 Furusho, 1984, High-dose intravenous gammaglobulin for Kawasaki disease, Lancet, ii, 1055, 10.1016/S0140-6736(84)91504-6 Newburger, 1986, The treatment of Kawasaki syndrome with intravenous gamma globulin, New England Journal of Medicine, 315, 341, 10.1056/NEJM198608073150601 Harada, 1991, Intravenous gamma-globulin treatment in Kawasaki disease, Acta Paediatrica Japonica, 33, 805, 10.1111/j.1442-200X.1991.tb02612.x Morikawa, 1994, A multicenter, randomized, controlled trial of intravenous gamma globulin therapy in children with acute Kawasaki disease, Acta Paediatrica Japonica, 36, 347, 10.1111/j.1442-200X.1994.tb03199.x Durongpisitkul, 1995, The prevention of coronary artery aneurysm in Kawasaki disease: a meta-analysis on the efficacy of aspirin and immunoglobulin treatment, Pediatrics, 96, 1057, 10.1542/peds.96.6.1057 Terai, 1997, Prevalence of coronary artery abnormalities in Kawasaki disease is highly dependent on gamma globulin dose but independent of salicylate dose, Journal of Pediatrics, 131, 888, 10.1016/S0022-3476(97)70038-6 Yanagawa, 1997, Use of intravenous gamma-globulin for Kawasaki disease: effects on cardiac sequelae, Pediatric Cardiology, 18, 19, 10.1007/s002469900102 Burns, 1998, Intravenous gamma-globulin treatment and retreatment in Kawasaki disease, Pediatric Infectious Disease Journal, 17, 1144, 10.1097/00006454-199812000-00009 Yanagawa, 1995, IV gamma globulin treatment of Kawasaki disease in Japan: results of a nationwide survey, Acta Paediatrica, 84, 765, 10.1111/j.1651-2227.1995.tb13752.x Yanagawa, 1995, Results of 12 nationwide epidemiological incidence surveys of Kawasaki disease in Japan, Archives of Pediatric Adolescent Medicine, 149, 779, 10.1001/archpedi.1995.02170200069011 Yanagawa, 2001, Incidence survey of Kawasaki disease in 1997 and 1998 in Japan, Pediatrics, 107, E33, 10.1542/peds.107.3.e33 Dajani, 1993, Diagnosis and therapy of Kawasaki disease in children, Circulation, 87, 1776, 10.1161/01.CIR.87.5.1776 Kusakawa, 1987, Efficacies and risks of aspirin in the treatment of the Kawasaki disease, Progress in Clinical and Biological Research, 250, 401 Melish, 1992, Comparison of low dose aspirin (LDA) vs. high dose aspirin (HDA) as an adjunct to intravenous gamma globulin (IVIG) in the treatment of Kawasaki syndrome (KS), Pediatric Research, 31, 170A Scuccimarri, 2001, Incidence of early cardiac abnormalities in children with Kawasaki disease treated with low dose aspirin and intravenous immunoglobulin in the acute phase, Arthritis & Rheumatism, 44, S169 Matsubara, 1996, Gastrointestinal hemorrhage complicating aspirin therapy in acute Kawasaki disease, Journal of Pediatrics, 128, 701, 10.1016/S0022-3476(96)80140-5 Koren, 1988, Determinants of low serum concentrations of salicylates in patients with Kawasaki disease, Journal of Pediatrics, 112, 663, 10.1016/S0022-3476(88)80194-X Koren, 1991, Decreased protein binding of salicylates in Kawasaki disease, Journal of Pediatrics, 118, 456, 10.1016/S0022-3476(05)82168-7 Scuccimarri, 2001, Thrombocytosis occurs early in Kawasaki disease, Arthritis & Rheumatism, 44, S169 Han, 2000, Recognition and management of Kawasaki disease, CMAJ, 162, 807 Bjoro, 1994, Hepatitis C infection in patients with primary hypogammaglobulinemia after treatment with contaminated immune globulin, New England Journal of Medicine, 331, 1607, 10.1056/NEJM199412153312402 Burns, 1991, Clinical and epidemiologic characteristics of patients referred for evaluation of possible Kawasaki disease, Journal of Pediatrics, 118, 680, 10.1016/S0022-3476(05)80026-5 Marasini, 1991, Late intravenous gamma globulin treatment in infants and children with Kawasaki disease and coronary artery abnormalities, American Journal of Cardiology, 68, 796, 10.1016/0002-9149(91)90658-8 Koren, 1986, Kawasaki disease: review of risk factors for coronary aneurysms, Journal of Pediatrics, 108, 388, 10.1016/S0022-3476(86)80878-2 Ichida, 1987, Coronary artery involvement in Kawasaki syndrome in Manhattan, New York: risk factors and role of aspirin, Pediatrics, 80, 828, 10.1542/peds.80.6.828 Melish, 1996, Kawasaki syndrome, Pediatric Reviews, 17, 153, 10.1542/pir.17-5-153 Reller, 1984, Coronary aneurysms in a patient with atypical Kawasaki syndrome and a streptococcal infection, Pediatric Cardiology, 5, 205, 10.1007/BF02427046 Holm, 1995, Kawasaki disease associated with parvovirus B19 infection, European Journal of Pediatrics, 154, 633, 10.1007/BF02079066 Johnson, 1985, Kawasaki disease associated with Klebsiella pneumoniae bacteremia and parainfluenza type 3 virus infection, Pediatric Infectious Disease, 4, 100, 10.1097/00006454-198501000-00024 Wallace, 2000, Initial intravenous gammaglobulin treatment failure in Kawasaki disease, Pediatrics, 105, E78, 10.1542/peds.105.6.e78 Sundel, 1993, Gamma globulin re-treatment in Kawasaki disease, Journal of Pediatrics, 123, 657, 10.1016/S0022-3476(05)80972-2 Wright, 1996, Treatment of immune globulin-resistant Kawasaki disease with pulsed doses of corticosteroids, Journal of Pediatrics, 128, 146, 10.1016/S0022-3476(96)70447-X Raman, 2001, Response of refractory Kawasaki disease to pulse steroid and cyclosporin A therapy, Pediatric Infectious Disease Journal, 20, 635, 10.1097/00006454-200106000-00022 Furukawa, 1994, Pentoxifylline and intravenous gamma globulin combination therapy for acute Kawasaki disease, European Journal of Pediatrics, 153, 663, 10.1007/BF02190688 Kato, 1979, Kawasaki disease: effect of treatment on coronary artery involvement, Pediatrics, 63, 175, 10.1542/peds.63.2.175 Nonaka, 1995 Dale, 2000, Treatment of severe complicated Kawasaki disease with oral prednisolone and aspirin, Journal of Pediatrics, 137, 723, 10.1067/mpd.2000.108444 Bierman, 1987, Kawasaki disease: clinical perspective, Journal of Pediatrics, 111, 789, 10.1016/S0022-3476(87)80269-X Haney, 1995, Ventricular arrhythmia complicating Kawasaki disease, Canadian Journal of Cardiology, 11, 931 Shetty, 1998, Massive lymphadenopathy and airway obstruction in a child with Kawasaki disease: success with pulse steroid therapy, Journal of Rheumatology, 25, 1215 Kato, 1992, Adult coronary artery disease probably due to childhood Kawasaki disease, Lancet, 340, 1127, 10.1016/0140-6736(92)93152-D Burns, 1996, Sequelae of Kawasaki disease in adolescents and young adults, Journal of the American College of Cardiology, 28, 253, 10.1016/0735-1097(96)00099-X Takahashi, 1987, Regression of coronary aneurysms in patients with Kawasaki syndrome, Circulation, 75, 387, 10.1161/01.CIR.75.2.387 Kato, 1996, Long-term consequences of Kawasaki disease. A 10- to 21-year follow-up study of 594 patients, Circulation, 94, 1379, 10.1161/01.CIR.94.6.1379 Nakano, 1985, Repeated quantitative angiograms in coronary arterial aneurysm in Kawasaki disease, American Journal of Cardiology, 56, 846, 10.1016/0002-9149(85)90767-2 Dajani, 1994, Guidelines for long-term management of patients with Kawasaki disease. Report from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young American Heart Association, Circulation, 89, 916, 10.1161/01.CIR.89.2.916 Rowley, 1999, Kawasaki syndrome, Pediatric Clinics of North America, 46, 313, 10.1016/S0031-3955(05)70120-6 Rhodes, 1996, Aerobic exercise function of patients with persistent coronary artery aneurysms secondary to Kawasaki disease, Pediatric Cardiology, 17, 226, 10.1007/BF02524798 Noto, 1996, Dobutamine stress echocardiography for detection of coronary artery stenosis in children with Kawasaki disease, Journal of the American College of Cardiology, 27, 1251, 10.1016/0735-1097(95)00570-6 Kondo, 1993, Scintigraphic monitoring of coronary artery occlusion due to Kawasaki disease, American Journal of Cardiology, 71, 681, 10.1016/0002-9149(93)91010-F Fukazawa, 1993, Discordance between thallium-201 scintigraphy and coronary angiography in patients with Kawasaki disease: myocardial ischemia with normal coronary angiogram, Pediatric Cardiology, 14, 67, 10.1007/BF00796982 Muzik, 1996, Quantification of myocardial blood flow and flow reserve in children with a history of Kawasaki disease and normal coronary arteries using positron emission tomography, Journal of the American College of Cardiology, 28, 757, 10.1016/0735-1097(96)00199-4 Ohmochi, 1995, Assessment of effects of intravenous dipyridamole on regional myocardial perfusion in children with Kawasaki disease without angiographic evidence of coronary stenosis using positron emission tomography and H2(15)O, Coronary Artery Disease, 6, 555 Tanaka, 1986, Pathological study of sequelae of Kawasaki disease (MCLS). With special reference to the heart and coronary arterial lesions, Acta Pathologica Japonica, 36, 1513 Sugimura, 1994, Intravascular ultrasound of coronary arteries in children. Assessment of the wall morphology and the lumen after Kawasaki disease, Circulation, 89, 258, 10.1161/01.CIR.89.1.258 Suzuki, 1996, Functional behavior and morphology of the coronary artery wall in patients with Kawasaki disease assessed by intravascular ultrasound, Journal of the American College of Cardiology, 27, 291, 10.1016/0735-1097(95)00447-5 Kato, 1995, Kawasaki disease, Coronary Artery Disease, 6, 194 Paridon, 1995, Exercise capacity and incidence of myocardial perfusion defects after Kawasaki disease in children and adolescents, Journal of the American College of Cardiology, 25, 1420, 10.1016/0735-1097(95)00003-M Dalzell, 1997, Coronary artery bypass grafting for Kawasaki disease at Children's Memorial Hospital, Chicago, Pediatric Research, 41, 118A, 10.1203/00006450-199704001-00716 Kitamura, 1994, Long-term outcome of myocardial revascularization in patients with Kawasaki coronary artery disease. A multicenter coopereative study, Journal of Thoracic and Cardiovascular Surgery, 107, 663, 10.1016/S0022-5223(94)70321-3 Checchia, 1997, Cardiac transplantation for Kawasaki disease, Pediatrics, 100, 695, 10.1542/peds.100.4.695 Iemura, 2000, Long term consequences of regressed coronary aneurysms after Kawasaki disease: vascular wall morphology and function, Heart, 83, 307, 10.1136/heart.83.3.307 Dhillon, 1996, Endothelial dysfunction late after Kawasaki disease, Circulation, 94, 2103, 10.1161/01.CIR.94.9.2103